Ways Douglas Kirk

Ways Douglas Kirk is listed in filings as Interim Chief Medical Officer at Spruce Biosciences, Inc.. This profile follows SEC Form 4 activity through Jan 21, 2026, including 6 public disclosures. Recent filings connect the profile to Spruce Biosciences, Inc. (SPRB). The current snapshot covers public activity from Jan 21, 2026. Reported amounts are shown as $210.5K to $27.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.